Document Detail


Radiesse nodule of the lips from a distant injection site: report of a case and consideration of etiology and management.
MedLine Citation:
PMID:  17763619     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Radiesse was approved for cosmetic use by the US FDA in December of 2006. Prior to this approval it had been widely used off-label for a variety of areas including lip augmentation. With increased use, complications including nodule formation were reported. The formation of nodules at a site distant from the area of injection has not been reported to date. This report documents such a case and discusses possible etiologies and treatments for these distant nodules.
Authors:
Kenneth Robert Beer
Related Documents :
16263649 - Pneumatosis intestinalis (pi) following severe traumatic brain injury.
23589789 - Role of hepcidin in the pathophysiology and diagnosis of anemia.
18166639 - Popliteal vein aneurysm: a case report and review of literature.
17211509 - Tongue piercing: case report of a local complication.
3700289 - Benzylpenicillin-induced neutropenia.
11174509 - Dilutional hyponatremia in preeclampsia with and without nephrotic syndrome.
3775269 - Primary throat anthrax. a report of six cases.
8826789 - A case of flutamide-induced acute cholestatic hepatitis--a case report.
15607219 - Fungal granuloma of the brain caused by cladosporium bantianum--a case report and revie...
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Journal of drugs in dermatology : JDD     Volume:  6     ISSN:  1545-9616     ISO Abbreviation:  J Drugs Dermatol     Publication Date:  2007 Aug 
Date Detail:
Created Date:  2007-09-03     Completed Date:  2007-09-25     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101160020     Medline TA:  J Drugs Dermatol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  846-7     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Biocompatible Materials / administration & dosage,  adverse effects
Cosmetic Techniques / adverse effects*
Durapatite / administration & dosage,  adverse effects*
Female
Humans
Hyaluronic Acid / administration & dosage
Injections
Lip Diseases / etiology*
Middle Aged
Skin Aging / drug effects
Chemical
Reg. No./Substance:
0/Biocompatible Materials; 1306-06-5/Durapatite; 9004-61-9/Hyaluronic Acid

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Combination of a new radiofrequency device and blue light for the treatment of acne vulgaris.
Next Document:  Fractional technology: a review and clinical approaches.